Norris Medicines Q3 Results

  • BSE: 524414
  • NSE: -
  • ISIN: INE744C01029
  • Sector: Biotechnology & Drugs
BSE
18.47-0.97 (-4.99%)
Volume2.49 K
Updated: Tue 26 Nov, 2024 | 11:09:59
NSE
This stock is not traded on NSE
Today: 18.47
19.05
52-Wk: 10.70
27.74

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Norris Medicines Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 22QoQ CompDec 22YoY Comp
    Total Revenue 0.653.03-%3.16-%
    Selling/ General/ Admin Expenses Total 0.340.60-%0.65-%
    Depreciation/ Amortization 0.140.15-%0.15-%
    Other Operating Expenses Total 0.00--%--%
    Total Operating Expense 0.832.94-%2.98-%
    Operating Income -0.180.08-%0.18-%
    Net Income Before Taxes -0.27-0.56-%-0.20-%
    Net Income -0.27-0.56-%-0.20-%
    Diluted Normalized EPS -0.27-0.56-%-0.20-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts